2023 Guidance
The following guidance assumes foreign exchange rates effective as of Dec. 31, 2022, for the full year. Enterprise level guidance includes the estimated impact from currently anticipated capital
Robust Growth in 2022 and Strong Outlook for 2023
"The Visteon team had a strong finish to round out a successful 2022, again achieving market out-performance along with 45 new program launches and $6 billion in
2023 sales growth is expected to be approximately 1% to 3% over 2022.
2023 sales of PPE products and COVID-19 test kits are expected to decrease in aggregate by